Cancer Nurse Comes Full Circle to Care for Families
As a kid, Hannah was inspired by the nurses who cared for her brother as he battled a brain tumor, so she became one herself.
As a kid, Hannah was inspired by the nurses who cared for her brother as he battled a brain tumor, so she became one herself.
Parents to 4-year-old Carter could never have known that a bump to his head during T-ball would lead to an unexpected discovery—a rare brain tumor.
When Jace Ward came to Lucile Packard Children’s Hospital Stanford to join a clinical trial for a novel therapy, he had been fighting a deadly brainstem tumor for more than a year. A group of Stanford scientists published data from the trial Ward joined.
On May 17, DIPG Awareness Day, four families who donated their late children’s brain tumor tissue to science convened at Stanford to hear firsthand from pediatric neuro-oncologist Michelle Monje, MD, PhD, about research developments and new clinical trials that may hold the key to unlocking treatment for Diffuse Intrinsic Pontine Glioma (DIPG).
It’s been more than seven years since Cole Rossi was cured of a rare brain cancer. The tumor and therapy left him with low levels of growth hormone, double vision, and physical weakness. He remains on hormone treatment and gets MRIs twice a year. He sees an oncologist every six months and a neurologist every other year.